Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line

---

Baccarani M., Castagnetti F., Simonsson B., Porkka K., HAZNEDAROĞLU İ. C., Nagler A., ...More

50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2008, vol.112, pp.75-76, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 112
• City: San-Francisco
• Country: Costa Rica
• Page Numbers: pp.75-76
• Istanbul University Affiliated: Yes